CD8A and acute myeloid leukemia: In 27 AML patients undergoing allogeneic stem cell transplantation, treatment with azacitidine augmented a graft-versus-leukemia (GVL) effect by inducing cytotoxic CD8+ T-cell responses to tumor antigens on leukemic blasts.